Profile of P-glycoprotien distribution in the rat and its possible influence on the salbutamol intestinal absorption process

Journal of Pharmaceutical Sciences

Volumn 93, Issue 6, 2004, Pages 1641-1648

  Valenzuela, Belén ^a   Nácher, Amparo ^a   Ruiz Carretero, Purificación ^a   Martín Villodre, Adela ^a   López Carballo, Gracia ^b   Barettino, Domingo ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CSIC   (Spain)

Author keywords

Bioavailability; Intestinal absorption; Intestinal secretion; MRNA; P glycoprotein (P gp) expression; Reverse transcription polymerase chain reaction (RT PCR); Salbutamol; Verapamil; Western blot

Indexed keywords

ANTIBODY; GLYCOPROTEIN P; INTESTINE ENZYME; MESSENGER RNA; SALBUTAMOL; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; COLON; DRUG ABSORPTION; INTESTINE; INTESTINE ABSORPTION; INTESTINE PERFUSION; INTESTINE SECRETION; KINETICS; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ALBUTEROL; ANIMALS; INTESTINAL ABSORPTION; MALE; P-GLYCOPROTEIN; RATS; RATS, WISTAR;

EID: 16544377891     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20071     Document Type: Article

References (25)

1. Pacifici GM, Giulianetti B, Quilici MC, Spisni R, Nervi M, Giuliani L, Gomeni R. 1997. (-)-Salbutamol sulphation in the human liver and duodenal mucosa: Interindividual variability. Xenobiotica 27:279-286.
2. Marchetti F, De Santi C, Vietri M, Pietrabissa A, Spisni R, Mosca F, Pacifici GM. 2001. Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine. Xenobiotica 31:841-847.
3. Taburet AM, Schmit B. 1994. Pharmacokinetic optimisation of asthma treatment. Clin Pharmacokinet 26:396-418.
4. Valenzuela B, Nácher A, Casabó VG, Martín-Villodre A. 2001. The influence of active secretion processes on intestinal absorption of salbutamol in the rat. Eur J Pharm Biopharm 52:31-37.
5. Gottesman MM, Pastan I. 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427.
6. Gottesman MM, Hrycyna CA, Schoenlein PV, Germann UA, Pastan I. 1995. Genetic analysis of the multidrug transporter. Annu Rev Genet 29:607-649.
7. Gottesman MM, Pastan I, Ambudkar SV. 1996. P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 6:610-617.
8. Ruetz S, Gros P. 1994. Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell 77:1071-1081.
9. Doluisio JT, Billups NF, Dittert LW, Sugita ET, Swintosky JV. 1969. Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates. J Pharm Sci 56:1196-2000.
10. Martín-Villodre A, Plá-Delfina JM, Moreno-Dalmau J, Pérez-Buendía MD, Miralles J, Collado E, Sánchez-Moyano E, Del Pozo A. 1986. Studies on the reliability of a bihyperbolic functional absorption model. I. Ring substituted anilines. J Pharmacokinet Biopharm 14:615-633.
11. Sánchez-Picó A, Peris-Ribera JE, Toledano C, Torres-Molina F, Casabó VG, Martín-Villodre A, Plá-Delfina JM. 1989. Nonlinear intestinal absorption kinetics of cefadroxil in the rat. J Pharm Pharmacol 41:179-185.
12. Fabra S, Climent E, Sanchís-Cortés A, Plá-Delfina JM. 1994. Compared effects of synthetic and natural bile acid surfactants on xenobiotic absorption. IV. Studies with taurocholate in the rat small intestine. Int J Pharm 109:197-207.
13. Sancho Chust V, Bengochea M, Fabra Campos S, Casabó VG, Martínez Cámara MJ, Martín-Villodre A. 1995. Experimental studies on the influence of surfactants on intestinal absorption of drugs. Cefadroxil as model drug and sodium laurylsulfate as model surfactant: Studies in rat duodenum. Arzneimittelforschung 45:1013-1017.
14. Karnes HT, March C. 1993. Precision, accuracy, and data acceptance criteria in biopharmaceutical analysis. Pharm Res 10:1420-1426.
15. Chomczynski P, Sacchi N. 1987. Single step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 162:156-159.
16. Silverman JA, Raunio H, Gant TW, Thorgeirsson SS. 1991. Cloning and characterization of a member of the rat multidrug resistance (mdr) gene family. Gene 106:229-236.
17. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ, Sutcliffe JG. 1988. p1B15: A cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261-267.
18. Laemmli K. 1970. Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature 227:680-685.
19. Saitoh H, Hatakeyama M, Eguchi O, Oda M, Takada M. 1997. Involvement of intestinal P-glycoprotein in the restricted absorption of methyl-prednisolone from rat small intestine. J Pharm Sci 87:73-75.
20. Nakayama A, Eguchi O, Hatakeyama M, Saitoh H, Takada M. 1999. Different absorption behaviors among steroid hormones due to possible interaction with P-glycoprotein in the rat small intestine. Biol Pharm Bull 22:535-538.
21. Chianale J, Vollrath V, Wielandt AM, Miranda S, Gonzalez R, Fresno AM, Gonzalez S, Andrade L, Guzman S. 1995. Differences between nuclear run-off and mRNA levels for multidrug resistance gene expression in the cephalocaudal axis of the mouse. Biochim Biophys Acta 1264:369-376.
22. Ficker G, Drewe J, Huwyler J, Gutmann H, Beglinger C. 1996. Relevance of P-glycoprotein for the enteral absorption of cyclosporin A: In vitro-in vivo correlation. Br J Pharmacol 118:1841-1847.
23. Sánchez-Castaño G, Ruiz-García A, Bañón N, Bermejo MV, Merino V, Freixas J, Garrigues TM, Plá-Delfina JM. 2000. Intrinsic absolute bioavailability prediction in rats, based on in situ absorption rate constants and/or in vitro partition coefficients: 6-Fluoroquinolones. J Pharm Sci 89:1395-1403.
24. Brady JM, Cherrington NJ, Hartley DP, Buist SC, Li N, Klaasen CD. 2002. Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metab Dispos 30:838-844.
25. Benet LZ, Cummins CL. 2001. The drug efflux-metabolism alliance: Biochemical aspects. Adv Drug Deliv Rev 50:S3-S11.